Spin-off news

Here you can find news from MPG spin-off companies.


Alnylam Announces FDA Approval of AMVUTTRA™ (vutrisiran), an RNAi Therapeutic for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults


Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy

Dewpoint Therapeutics

Dewpoint Therapeutics Granted Foundational Platform Technology Patent by US Patent Office


Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1


Proteros expands oncology collaboration and license agreement with Astrazeneca